BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 3
• 4
• 5
• 6
• 7
• 10
• 11
• 12
• 13
• 14
• 17
• 18
• 19
• 20
• 21
• 24
• 25
• 26
• 27
• 28
• 30
• 31

• Novo Nordisk A/S - Share Repurchase Programme

  March 24, 2014

   · 

  1 min read
• Antibe Therapeutics Inc. Announces Non-Brokered Private Placement Of $3,000,000

  March 24, 2014

   · 

  1 min read
• Policy

  Gilead Sciences, Inc.'s $84,000 Treatment Questioned By U.S. Lawmakers

  March 24, 2014

   · 

  1 min read
• Ex-Pfizer Inc. Exec Takes Position At Promising Startup, Innovative Med Concepts'; Company On The Verge Of Finding Fibromyalgia Cure

  March 24, 2014

   · 

  1 min read
• FDA

  Novartis AG Announces FDA Approval Of Xolair® (Omalizumab) For Chronic Idiopathic Urticaria (CIU), A Form Of Chronic Hives

  March 24, 2014

   · 

  12 min read
• Novartis AG Chairman Stresses Need For R&D Investment

  March 24, 2014

   · 

  1 min read
• Drug Development

  Bay Area’s InterMune, Inc. Gains As Boehringer Ingelheim Corporation’s Rival Drug Shows Mixed Results

  March 24, 2014

   · 

  1 min read
• Drug Development

  Celgene Release: Oral OTEZLA® (Apremilast) Demonstrated Clinically Meaningful And Sustained Improvements In Skin, Nail And Scalp Of Adult Patients With Moderate To Severe Plaque Psoriasis

  March 24, 2014

   · 

  1 min read
• 5 Ways Employers Can Attract The Best Candidates

  March 24, 2014

   · 

  3 min read